The story of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in sales , its patent expiration created a wave of lower-priced alternatives , significantly eroding its dominance. While specific businesses may attempt to capitalize on similar conditions , the curre